Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial-Reference-Cited by-同舟云学术

Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial

Published:2018-12-05 Issue:2 Volume:40 Page:167-176
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Byrne Robert A¹²,Alfonso Fernando³,Schneider Simon⁴,Maeng Michael⁵,Wiebe Jens¹,Kretov Evgeny⁶,Bradaric Christian⁴,Rai Himanshu¹,Cuesta Javier³,Rivero Fernando³,Hoppmann Petra⁴,Schlichtenmaier Jana⁴,Christiansen Evald H⁵,Cassese Salvatore¹,Joner Michael¹²,Schunkert Heribert¹²,Laugwitz Karl-Ludwig²⁴,Kastrati Adnan¹²

Affiliation:

1. Department of Cardiovascular Diseases, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse 36, Munich, Germany

2. DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany

3. Cardiac Department, Hospital Universitario de La Princesa Madrid, Madrid, Spain

4. Clinic and Policlinic Internal Medicine I (Cardiology and Angiology), Klinikum rechts der Isar, Technische Universität München, Munich, Germany

5. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark

6. E.N. Meshalkin National Medical Research Center, Novosibirsk, Russia

Funder

Deutsches Herzzentrum München

Abbott Vascular

Publisher

Oxford University Press (OUP)